Hackensack Meridian Health Hackensack University Medical Center today announced that the medical center is among the first hospitals in New Jersey to offer a cutting-edge treatment to regrow and implant a patient’s own cartilage cells to regenerate knee cartilage. Surgeons at Hackensack University Medical Center are now using MACI (autologous cultured chondrocytes on porcine collagen membrane) implants to treat patients with cartilage defects.
“Hackensack University Medical Center’s renowned sports medicine and orthopedics department has been leading the way in knee cartilage repair for two decades, and we look forward to using the MACI implant to positively impact our patient’s lives,” said Michael Kelly, M.D., chair, Department of Orthopaedic Surgery and Sports Medicine and chair, Department of Physical Medicine and Rehabilitation Hackensack University Medical Center. “Our team members will use this latest, less invasive technology to regrow a patient’s own cartilage cells in a laboratory and implant them to regenerate knee cartilage.”
This state-of-the-art technology reproduces a patient’s own cells using autologous cultured chondrocytes that are seeded onto a resorbable collagen membrane. MACI requires smaller incisions and less scar tissue cleanup, which ultimately results in faster recovery and rehabilitation time for patients. Ideal candidates for MACI implants are younger, active adults with full thickness symptomatic articular cartilage defects of the knee.
“Hackensack University Medical Center’s Sports Medicine and Orthopedic Surgery department has consistently been on the forefront of innovative technology. We are proud to be among the first hospitals in New Jersey to offer this new advanced, cutting edge treatment to regrow and regenerate cartilage in the injured knee,” said James W. Cahill, M.D., senior orthopedic surgery attending, Hackensack University Medical Center, who is performing the MACI surgeries. “Utilizing advanced biologic technology such as MACI, we can now heal larger cartilage defects with the patient’s own cells. I am confident MACI will result in a better more natural, longer lasting repair that better restores cartilage compared to prior techniques. Recovery and quality of life will significantly improve.”
MACI was approved by the U.S. Food & Drug Administration (FDA) in December 2016 and is the latest generation of ACI, which Dr. Cahill and Hackensack University Medical Center has been successfully performing for nearly two decades. In 1999, Hackensack University Medical Center was among the first hospitals in New Jersey to perform ACI procedures.
Hackensack University Medical Center has a renowned sports medicine and orthopedics department. Dr. Cahill performed one of the first ACI surgeries in 1999 at Hackensack University Medical Center and has two decades of expertise in knee cartilage repair. He is a fellowship trained sports medicine and reconstruction specialist, and routinely performs arthroscopic and joint replacement surgery of the shoulders, elbow, hip and knee. He has lectured on and participated in original research for the treatment of cartilage injuries that ultimately require cartilage repair and reconstruction.